Javascript must be enabled to continue!
Fatty liver formation in fulminant type 1 diabetes
View through CrossRef
SummaryA 32-year-old woman presented with 3days of epigastric pain and was admitted to our hospital (day 3 of disease). We diagnosed acute pancreatitis based on epigastric abdominal pain, hyperamylasemia, and an inflammatory reaction of withdrawn blood, pancreatic enlargement, and so on. Her condition improved with treatment; however, on day 8, she had decreased level of consciousness. Laboratory results led to a diagnosis of fulminant type 1 diabetes mellitus (FT1DM) with concomitant diabetic ketoacidosis. Insulin therapy improved her blood glucose levels as well as her symptoms. Fatty liver with liver dysfunction was observed on day 14, which improved by day 24. Blood levels of free fatty acids (FFAs) increased rapidly from 440μEq/L (normal range: 140–850μEq/L) on day 4 to 2097μEq/L on days 7–8 (onset of FT1DM) and subsequently decreased to 246μEq/L at the onset of fatty liver. The rapid decrease in insulin at the onset of FT1DM likely freed fatty acids derived from triglycerides in peripheral adipocytes into the bloodstream. Insulin therapy rapidly transferred FFAs from the periphery to the liver. In addition, insulin promotes thede novosynthesis of triglycerides in the liver, using newly acquired FFAs as substrates. At the same time, inhibitory effects of insulin on VLDL secretion outside of the liver promote the accumulation of triglycerides in the liver, leading to fatty liver. We describe the process by which liver dysfunction and severe fatty liver occurs after the onset of FT1DM, from the perspective of disturbed fatty acid metabolism.Learning pointsFT1DM is rare but should be considered in patients with pancreatitis and a decreased level of consciousness.Fatty liver should be considered in patients with FT1DM when liver dysfunction is observed.Insulin is involved in mechanisms that promote fatty liver formation.Pathophysiological changes in fatty acid metabolism may provide clues on lipid metabolism in the early phases of FT1DM.
Title: Fatty liver formation in fulminant type 1 diabetes
Description:
SummaryA 32-year-old woman presented with 3days of epigastric pain and was admitted to our hospital (day 3 of disease).
We diagnosed acute pancreatitis based on epigastric abdominal pain, hyperamylasemia, and an inflammatory reaction of withdrawn blood, pancreatic enlargement, and so on.
Her condition improved with treatment; however, on day 8, she had decreased level of consciousness.
Laboratory results led to a diagnosis of fulminant type 1 diabetes mellitus (FT1DM) with concomitant diabetic ketoacidosis.
Insulin therapy improved her blood glucose levels as well as her symptoms.
Fatty liver with liver dysfunction was observed on day 14, which improved by day 24.
Blood levels of free fatty acids (FFAs) increased rapidly from 440μEq/L (normal range: 140–850μEq/L) on day 4 to 2097μEq/L on days 7–8 (onset of FT1DM) and subsequently decreased to 246μEq/L at the onset of fatty liver.
The rapid decrease in insulin at the onset of FT1DM likely freed fatty acids derived from triglycerides in peripheral adipocytes into the bloodstream.
Insulin therapy rapidly transferred FFAs from the periphery to the liver.
In addition, insulin promotes thede novosynthesis of triglycerides in the liver, using newly acquired FFAs as substrates.
At the same time, inhibitory effects of insulin on VLDL secretion outside of the liver promote the accumulation of triglycerides in the liver, leading to fatty liver.
We describe the process by which liver dysfunction and severe fatty liver occurs after the onset of FT1DM, from the perspective of disturbed fatty acid metabolism.
Learning pointsFT1DM is rare but should be considered in patients with pancreatitis and a decreased level of consciousness.
Fatty liver should be considered in patients with FT1DM when liver dysfunction is observed.
Insulin is involved in mechanisms that promote fatty liver formation.
Pathophysiological changes in fatty acid metabolism may provide clues on lipid metabolism in the early phases of FT1DM.
Related Results
Grading of Fatty Liver Disease in Non-Obese Elderly Patients On Ultrasound
Grading of Fatty Liver Disease in Non-Obese Elderly Patients On Ultrasound
Background and Introduction: Non-alcoholic fatty liver disease (NAFLD) has been demonstrated that insulin resistance and metabolic syndrome are associated with non-alcoholic fatty ...
The Value of Quantitative Ultrasound Elastography in the Assessment of Non-Alcoholic Fatty Liver Disease in Children
The Value of Quantitative Ultrasound Elastography in the Assessment of Non-Alcoholic Fatty Liver Disease in Children
Objective:
This preliminary investigation aimed to assess the value of two elastography techniques, sound touch elastography (STE) and sound touch
quantification (STQ), in measurin...
A Multi-Polygenic Risk Score Approach Incorporating Physical Activity Genotypes for Predicting Type 2 Diabetes and Associated Comorbidities: A FinnGen Study
A Multi-Polygenic Risk Score Approach Incorporating Physical Activity Genotypes for Predicting Type 2 Diabetes and Associated Comorbidities: A FinnGen Study
ABSTRACT
Aims/hypothesis
Genetic prediction of type 2 diabetes risk has proven difficult using current methods. Recent studies have shown...
Diabetes Awareness Among High School Students in Qatar
Diabetes Awareness Among High School Students in Qatar
Diabetes is a disease that occurs when there is an abundance of glucose in the blood stream and the body cannot produce enough insulin in the pancreas to transfer the sugar from th...
Pendidikan dan promosi kesehatan tentang diabetes mellitus
Pendidikan dan promosi kesehatan tentang diabetes mellitus
Health education and promotion about diabetes mellitus
Introduction: Diabetes mellitus in Indonesia is a serious threat to health development. The 2010 NCD World Health Organizatio...
Diabetes Prediction Using Machine Learning
Diabetes Prediction Using Machine Learning
The research analyzes machine learning methods for predicting diabetes through Pima Indians Diabetes Dataset analysis. The optimization of XGBoost and Logistic Regression (LR), Sup...
Effect and Safety of Pioglitazone-Metformin Tablets in the Treatment of Newly Diagnosed Type 2 Diabetes Patients with Nonalcoholic Fatty Liver Disease in Shaanxi Province: A Randomized, Double-Blinded, Double-Simulated Multicenter Study
Effect and Safety of Pioglitazone-Metformin Tablets in the Treatment of Newly Diagnosed Type 2 Diabetes Patients with Nonalcoholic Fatty Liver Disease in Shaanxi Province: A Randomized, Double-Blinded, Double-Simulated Multicenter Study
Objective. The aim of study was to evaluate the effect and safety of pioglitazone-metformin combined treatment in the newly diagnosed type 2 diabetes patients with nonalcoholic fat...
Investigation of the regulatory mechanisms of Guiqi Yimu Powder on dairy cow fatty liver cells using a multi-omics approach
Investigation of the regulatory mechanisms of Guiqi Yimu Powder on dairy cow fatty liver cells using a multi-omics approach
IntroductionFatty liver disease in dairy cows is a metabolic disorder that significantly affects their health and productivity, imposing a notable economic burden on the global dai...


